AstraZeneca PLC (AZN)
91.51
+1.69
(+1.88%)
USD |
NASDAQ |
Dec 10, 16:00
90.99
-0.52
(-0.57%)
Pre-Market: 08:44
AstraZeneca Profit Margin (Quarterly): 16.69% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GSK Plc | 25.08% |
| Amgen, Inc. | 33.55% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Autolus Therapeutics Plc | -373.3% |
| Moderna, Inc. | -19.68% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.01% |
| Return on Assets | 8.67% |
| Return on Invested Capital | 12.62% |
| Gross Profit Margin (Quarterly) | 73.89% |
| Operating Margin (Quarterly) | 23.52% |
| Return on Net Operating Assets | 10.40% |